Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection

被引:16
作者
Ramos Antuna, Aida [1 ]
Alvarez Vega, Marco [1 ]
Rodriguez Sanchez, Carmen [2 ]
Martin Fernandez, Vanesa [2 ]
机构
[1] Hosp Univ Cent Asturias, Dept Neurosurg, Ave Roma Oviedo, Oviedo 33006, Asturias, Spain
[2] Univ Oviedo, Sch Med, Morphol & Cell Biol, Oviedo, Asturias, Spain
关键词
non-small cell lung cancer; brain metastases; prognostic factors; surgical resection; SPECIAL TREATMENT ISSUES; LONG-TERM SURVIVAL; STEREOTACTIC RADIOSURGERY; RADIATION-THERAPY; CEREBRAL METASTASES; EGFR MUTATION; RISK-FACTORS; SURGERY; MANAGEMENT; CARCINOMA;
D O I
10.1055/s-0037-1601874
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Study Aims Bronchogenic carcinoma is the cancer that most commonly metastasizes to the brain. The standard treatment schedule for these patients is still unclear, although recommendation level 1 class I advocates for surgical resection together with postoperative whole-brain radiotherapy for patients with good Karnofsky performance status (KPS). We performed a study to identify prognostic factors for the long-term survival of patients with brain metastases from non-small cell lung cancer (NSCLC). Patients This retrospective single-center study included 71 patients with brain metastases from NSCLC having undergone surgical metastasectomy between January 2002 and January 2015. Results The average age was 58.8 years. A total of 85.9% of the lesions were located in the supratentorial region, 61.9% of the lesions were<3 cm, and 80.3% of cases were solitary brain metastases. Complete resection was achieved in 90.1% of patients. Clinical debut with motor involvement was associated with higher rates of incomplete surgical resection. Patients with motor deficits had a worse preoperative KPS. The preoperative KPS was>70 in 74.6% of patients, and the postoperative KPS was>70 in 85.9% of patients. Overall, 84.5% of the brain surgeries had no complications. Brain metastases were diagnosed as a synchronous presentation in 64.7% of patients. The average survival after brain surgery was 20.38 months. The survival rate was 66.2% at 6 months, 45.1% at 12 months, 22.5% at 24 months, 14.1% at 36 months, and 8.5% at 48 months. Patients<55 years of age showed a higher survival rate at 12 months and 48 months. Patients>70 years of age showed a higher mortality rate at 6 months. Complete surgical brain metastasis resection was associated with an increased survival at 6 months, and patients undergoing primary lung surgery had better survival rates at 48 months. A preoperative KPS>70% improved the prognosis of patients at 6 and 24 months. Surgical complications reduced survival at 6 and 12 months. Conclusion Surgical resection may be beneficial for a given group of patients: a preoperative KPS>70; age<55 years, complete surgical brain metastasis resection, no surgical complications, patients with primary lung surgery, and complete radiotherapy treatment. We did not find any significant difference regarding further factors that probably affect survival rates such as size or number of metastases.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 49 条
[1]   Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients [J].
Abrahams, JM ;
Torchia, M ;
Putt, M ;
Kaiser, LR ;
Judy, KD .
JOURNAL OF NEUROSURGERY, 2001, 95 (04) :595-600
[2]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[3]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[4]   Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery [J].
Arita, Hideyuki ;
Narita, Yoshitaka ;
Miyakita, Yasuji ;
Ohno, Makoto ;
Sumi, Minako ;
Shibui, Soichiro .
JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (01) :145-152
[5]  
Barlesi Fabrice, 2013, Bull Cancer, V100, P303, DOI 10.1684/bdc.2013.1721
[6]   Surgery versus radiosurgery in the treatment of brain metastasis [J].
Bindal, AK ;
Bindal, RK ;
Hess, KR ;
Shiu, A ;
Hassenbusch, SJ ;
Shi, WM ;
Sawaya, R .
JOURNAL OF NEUROSURGERY, 1996, 84 (05) :748-754
[7]   Surgical management of non-small cell lung cancer with synchronous brain metastases [J].
Bonnette, P ;
Puyo, P ;
Gabriel, C ;
Giudicelli, R ;
Regnard, JF ;
Riquet, M ;
Brichon, PY .
CHEST, 2001, 119 (05) :1469-1475
[8]   EGFR mutation status in brain metastases of non-small cell lung carcinoma [J].
Burel-Vandenbos, Fanny ;
Ambrosetti, Damien ;
Coutts, Michael ;
Pedeutour, Florence .
JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) :1-10
[9]   Identifying Better Surgical Candidates Among Recursive Partitioning Analysis Class 2 Patients who Underwent Surgery for Intracranial Metastases [J].
Chaichana, Kaisorn L. ;
Acharya, Shami ;
Flores, Mariana ;
Wijesekera, Olindi ;
Rigamonti, Daniele ;
Weingart, Jon D. ;
Olivi, Alessandro ;
Bettegowda, Chetan ;
Gallia, Gary L. ;
Brem, Henry ;
Lim, Michael ;
Quinones-Hinojosa, Alfredo .
WORLD NEUROSURGERY, 2014, 82 (1-2) :E267-E275
[10]   Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer - Clinical implications for the subsequent management of the brain [J].
Chen, Allen M. ;
Jahan, Thierry M. ;
Jablons, David M. ;
Garcia, Joaquin ;
Larson, David A. .
CANCER, 2007, 109 (08) :1668-1675